Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Change in Intangibles (2023 - 2025)

Adma Biologics (ADMA) has disclosed Change in Intangibles for 3 consecutive years, with $192000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Intangibles rose 2842.86% year-over-year to $192000.0, compared with a TTM value of $316000.0 through Dec 2025, down 9.46%, and an annual FY2025 reading of $316000.0, down 9.46% over the prior year.
  • Change in Intangibles was $192000.0 for Q4 2025 at Adma Biologics, up from $105000.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $299000.0 in Q2 2024 and bottomed at -$7000.0 in Q4 2024.
  • Average Change in Intangibles over 3 years is $109375.0, with a median of $73500.0 recorded in 2024.
  • The sharpest move saw Change in Intangibles tumbled 103.33% in 2024, then surged 2842.86% in 2025.
  • Year by year, Change in Intangibles stood at $210000.0 in 2023, then plummeted by 103.33% to -$7000.0 in 2024, then soared by 2842.86% to $192000.0 in 2025.
  • Business Quant data shows Change in Intangibles for ADMA at $192000.0 in Q4 2025, $105000.0 in Q2 2025, and $19000.0 in Q1 2025.